The clinical trial is run by National Cancer Institute to apply Pembrolizumab in treating locally advanced bladder cancer.
Trial Name: Pembrolizumab in Treating Patients with Locally Advanced Bladder Cancer
Age: 18 years and over
Gender: Male or Female
Location: 407 locations
Pembrolizumab, trade name KEYTRUDA, is a medicine that may treat certain cancers by working with your immune system.
Please find details on www.cancer.gov